Your browser doesn't support javascript.
loading
The Yersinia pestis Effector YopM Inhibits Pyrin Inflammasome Activation.
Ratner, Dmitry; Orning, M Pontus A; Proulx, Megan K; Wang, Donghai; Gavrilin, Mikhail A; Wewers, Mark D; Alnemri, Emad S; Johnson, Peter F; Lee, Bettina; Mecsas, Joan; Kayagaki, Nobuhiko; Goguen, Jon D; Lien, Egil.
Affiliation
  • Ratner D; UMass Medical School, Program in Innate Immunity, Division of Infectious Diseases and Immunology, Department of Medicine, Worcester, Massachusetts, United States of America.
  • Orning MP; UMass Medical School, Program in Innate Immunity, Division of Infectious Diseases and Immunology, Department of Medicine, Worcester, Massachusetts, United States of America.
  • Proulx MK; Centre of Molecular Inflammation Research, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
  • Wang D; UMass Medical School, Department of Microbiology and Physiological Systems, Worcester, Massachusetts, United States of America.
  • Gavrilin MA; UMass Medical School, Program in Innate Immunity, Division of Infectious Diseases and Immunology, Department of Medicine, Worcester, Massachusetts, United States of America.
  • Wewers MD; Department of Medicine, School of Medicine, Duke University, Durham, North Carolina, United States of America.
  • Alnemri ES; Davis Heart and Lung Research Institute, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Internal Medicine, Wexner Medical Center, The Ohio State University, Columbus, Ohio, United States of America.
  • Johnson PF; Davis Heart and Lung Research Institute, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Internal Medicine, Wexner Medical Center, The Ohio State University, Columbus, Ohio, United States of America.
  • Lee B; Department of Biochemistry and Molecular Biology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America.
  • Mecsas J; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America.
  • Kayagaki N; Department of Physiological Chemistry, Genentech, Inc., South San Francisco, California, United States of America.
  • Goguen JD; Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, United States of America.
  • Lien E; Department of Physiological Chemistry, Genentech, Inc., South San Francisco, California, United States of America.
PLoS Pathog ; 12(12): e1006035, 2016 Dec.
Article in En | MEDLINE | ID: mdl-27911947
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Plague / Bacterial Outer Membrane Proteins / Inflammasomes / Pyrin Type of study: Prognostic_studies Limits: Animals Language: En Journal: PLoS Pathog Year: 2016 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Plague / Bacterial Outer Membrane Proteins / Inflammasomes / Pyrin Type of study: Prognostic_studies Limits: Animals Language: En Journal: PLoS Pathog Year: 2016 Type: Article Affiliation country: United States